WASHINGTON, June 17 -- ACS Medicinal Chemistry Letters, a peer-reviewed journal from the American Chemical Society that says it features biological evaluation, drug delivery, imaging agents and pharmacology of small and large bioactive molecules, published research articles on the following topics in its June 13, 2024, edition (Vol. 15, Issue 6):

Patent Highlights:

* Novel 2,7-Naphthyridine Compounds as MASTL Inhibitors for Treating Cancer

* Lysosomal Degra . . .

Click here for more information about our products